Thursday, 11 November 2010

Stem Cell Transplants in Mice Produce Lifelong Enhancement of Muscle Mass

Findings may have potential for future treatment of patients with chronic, degenerative muscle diseases
Thursday, 11 November 2010

A University of Colorado at Boulder-led study shows that specific types of stem cells transplanted into the leg muscles of mice prevented the loss of muscle function and mass that normally occurs with aging, a finding with potential uses in treating humans with chronic, degenerative muscle diseases.

The experiments showed that when young host mice with limb muscle injuries were injected with muscle stem cells from young donor mice, the cells not only repaired the injury within days, they caused the treated muscle to double in mass and sustain itself through the lifetime of the transplanted mice.

"This was a very exciting and unexpected result," said Professor Bradley Olwin of CU-Boulder's molecular, cellular and developmental biology department, the study's corresponding author.

Muscle stem cells are found within populations of "satellite" cells located between muscle fibres and surrounding connective tissue and are responsible for the repair and maintenance of skeletal muscles, said Olwin. The researchers transplanted between 10 and 50 stem cells along with attached myofibers – which are individual skeletal muscle cells – from the donor mice into the host mice.

"We found that the transplanted stem cells are permanently altered and reduce the aging of the transplanted muscle, maintaining strength and mass," said Olwin.

A paper on the subject was published in the Nov. 10 issue of Science Translational Medicine. Co-authors on the study included former CU-Boulder postdoctoral fellow John K. Hall, now at the University of Washington Medical School in Seattle, as well as Glen Banks and Jeffrey Chamberlain of the University of Washington Medical School.

Olwin said the new findings, while intriguing, are only the first in discovering how such research might someday be applicable to human health.

"With further research we may one day be able to greatly resist the loss of muscle mass, size and strength in humans that accompanies aging, as well as chronic degenerative diseases like muscular dystrophy."

Stem cells are distinguished by their ability to renew themselves through cell division and differentiate into specialized cell types. In healthy skeletal muscle tissue, the population of satellite stem cells is constantly maintained, said Olwin.

"In this study, the hallmarks we see with the aging of muscles just weren't occurring," said Olwin.

"The transplanted material seemed to kick the stem cells to a high gear for self-renewal, essentially taking over the production of muscle cells. But the team found that when transplanted stem cells and associated myofibers were injected to healthy mouse limb muscles, there was no discernable evidence for muscle mass growth.”

"The environment that the stem cells are injected into is very important, because when it tells the cells there is an injury, they respond in a unique way," he said.

"We don't yet know why the cells we transplanted are not responding to the environment around them in the way that the cells that are already there respond. It's fascinating, and something we need to understand."

At the onset of the experiments, the research team thought the increase in muscle mass of the transplanted mice with injured legs would dissipate within a few months. Instead, the cells underwent a 50 percent increase in mass and a 170 percent increase in size and remained elevated through the lifetime of the mice – roughly two years, said Olwin.

In the experiments, stem cells and myofibers were removed from three-month-old mice, briefly cultured and then transplanted into three-month-old mice that had temporarily induced leg muscle injuries produced by barium chloride injections.

"When the muscles were examined two years later, we found the procedure permanently changed the transplanted cells, making them resistant to the aging process in the muscle," he said.

"This suggests a tremendous expansion of those stem cells after transplantation," Olwin said. Fortunately, the research team saw no increase in tumours in the transplanted mice despite the rapid, increased growth and production of muscle stem cells.

As part of the research effort, the team used green fluorescent protein – which glows under ultraviolet light – to flag donor cells in the injected mice. The experiment indicated many of the transplanted cells were repeatedly fused to myofibers, and that there was a large increase in the number of satellite cells in the host mice.

"We expected the cells to go in, repopulate and repair damaged muscle and to dissipate," Olwin said. "It was quite surprising when they did not.”

"It is our hope that we can someday identify small molecules or combinations of small molecules that could be applied to endogenous muscle stem cells of humans to mimic the behaviour of transplanted cells," Olwin said.

"This would remove the need for cell transplants altogether, reducing the risk and complexity of treatments."

But Olwin said it is important to remember that the team did not transplant young cells into old muscles, but rather transplanted young cells into young muscles.

The research has implications for a number of human diseases, Olwin said. In muscular dystrophy, for example, there is a loss of a protein called dystrophin that causes the muscle to literally tear itself apart and cannot be repaired without cell-based intervention. Although injected cells will repair the muscle fibres, maintaining the muscle fibres requires additional cell injections, he said.

"Progressive muscle loss occurs in a number of neuromuscular diseases and in muscular dystrophies," he said.

"Augmenting a patient's muscle regenerative process could have a significant impact on aging and diseases, improving the quality of life and possibly improving mobility."

Olwin said the research team is beginning experiments to see if transplanting muscle stem cells from humans or large animals into mice will have the same effects as those observed in the recent mouse experiments.

"If those experiments produce positive results, it would suggest that transplanting human muscle stem cells is feasible," he said.

Source: University of Colorado at Boulder
Contact: Bradley Olwin
.........


ZenMaster


For more on stem cells and cloning, go to CellNEWS at
http://cellnews-blog.blogspot.com/

MicroRNA Controls Mammary Gland Development in Mice

Max Planck researchers discover novel mechanism for vertebrate organ development
Thursday, 11 November 2010

Hormones, growth factors and several proteins ensure that development occurs in the right way, at the right time. The components that cause breast development in mammals, for example, were thought to be largely known. However, as a team of scientists from Göttingen, Frankfurt and Hanover have now discovered, in the case of breast development, hormones and proteins do not account for the full story. The scientists have shown that tiny ribonucleic acid molecules play a key role in this process. The mammary glands of mice lacking the gene for the microRNAs 212 and 132 failed to grow at puberty.

The scientists have demonstrated for the first time in an animal model that small ribonucleic acid molecules, so-called microRNAs, also fulfil an important function in organ development.

"This came as a surprise to us," says project leader Kamal Chowdhury from the Max Planck Institute for Biophysical Chemistry in Göttingen.

"The mice used in our experiments had all of the hormones, growth factors and proteins that ensure normal breast development. But the absence of the microRNAs miR-212 and miR-132 resulted in the complete failure of duct development in the mammary glands of mice."



Mammary gland tissue of milk-producing mice with (left) and without (right) miR-212/132: the consequences of the lack of the ribonucleic acid molecules are clear to see. The milk ducts (dark red) did not grow in the tissue without the microRNAs. Credit: Image: Max Planck Institute for Biophysical Chemistry.


It is well known that microRNAs perform very important regulatory functions inside living cells. Although they do not code for proteins, they are responsible for the fine-tuning of the production of certain proteins and intervene extensively in metabolic processes. The question is however: how does this activity shape the morphology of the whole organism?

"Using various experiments, we were able to demonstrate that this RNA family plays a key role in mammary gland development and we could locate where these molecules presumably intervene on a regulatory basis," explains Chowdhury.

The mammary gland, which is also known as the milk gland, consists of the milk ducts and the surrounding connective tissue, which has a supportive and regulatory function. The connective tissue also appears to be the location where miR-212 and miR-132 are produced and intervene in the developmental process. Chowdhury and his colleague Ahmet Ucar were able to demonstrate with their experiments that this is the only place where the genes for these ribonucleic acid molecules are "switched on" in the breast tissue.

Molecular dimmer
According to the researcher's model, the microRNA molecules appear to control the production of a protein called MMP-9.

"The microRNAs can down-regulate the production of MMP-9, like a dimmer switch," explains Ucar. If the microRNAs are missing, more MMP-9 proteins are produced and they accumulate near the milk ducts. They appear to activate a signalling pathway there, which prevents the normal growth of the milk ducts in the glandular tissue.

"These tiny RNA molecules carry out their regulatory function by influencing the communication between the two tissues of the mammary gland," says Ucar. Other experiments now need to be carried out to examine whether these microRNAs also regulate breast development in humans. At the moment, the scientists can only speculate about what happens when the microRNAs do not function correctly.

"Whether such malfunctions can lead to the formation of tumours, for example, is something that needs to be examined in further studies," says Chowdhury.

Source: Max-Planck-Gesellschaft
Contact: Kamal Chowdhury

Reference:
miR-212 and miR-132 are required for epithelial stromal interactions and mouse mammary gland development
Ahmet Ucar, Vida Vafaizadeh, Hubertus Jarry, Jan Fiedler, Petra A B Klemmt, Thomas Thum, Bernd Groner, and Kamal Chowdhury
Nature Genetics, advanced online publication, November 7, 2010
.........


ZenMaster

For more on stem cells and cloning, go to CellNEWS at
http://cellnews-blog.blogspot.com/

Sunday, 7 November 2010

Scientists Turn Skin Cells into Blood

Making blood from skin cells does not require the middle step of changing a skin stem cell into a pluripotent stem cell
Sunday, 07 November 2010

In an important breakthrough, scientists at McMaster University have discovered how to make human blood from adult human skin.

The discovery, published in the prestigious science journal Nature today, could mean that in the foreseeable future people needing blood for surgery, cancer treatment or treatment of other blood conditions like anaemia will be able to have blood created from a patch of their own skin to provide transfusions. Clinical trials could begin as soon as 2012.

Mick Bhatia, scientific director of McMaster’s Stem Cell and Cancer Research Institute in the Michael G. DeGroote School of Medicine, and his team of researchers have also shown that the conversion is direct. Making blood from skin does not require the middle step of changing a skin stem cell into a pluripotent stem cell that could make many other types of human cells, then turning it into a blood stem cell.

“We have shown this works using human skin. We know how it works and believe we can even improve on the process,” said Bhatia.

“We’ll now go on to work on developing other types of human cell types from skin, as we already have encouraging evidence.”

The discovery was replicated several times over two years using human skin from both young and old people to prove it works for any age of person.

This research was funded by the Canadian Institutes of Health Research, the Canadian Cancer Society Research Institute, the Stem Cell Network and the Ontario Ministry of Research and Innovation.

“CIHR is proud to invest in the excellent research that is being undertaken by Mick Bhatia’s laboratory at the Stem Cell and Cancer Research Institute at McMaster University,” said Alain Beaudet, president of the Canadian Institutes for Health Research.

“The Bhatia research effort is building on significant findings in recent years, which have shown that human skin cells can be reprogrammed into pluripotent cells that have the potential to become all cell types."

"The pioneering findings published today are the first to demonstrate that human skin cells can be directly converted into blood cells, via a programming process that bypasses the pluripotent stage. Producing blood from a patient’s own skin cells, has the potential of making bone marrow transplant HLA matching and paucity of donors a thing of the past.”

John Kelton, haematologist and dean and vice-president of health sciences for McMaster University said:

“I find this discovery personally gratifying for professional reasons.”

"During my 30 years as a practicing blood specialist, my colleagues and I have been pleased to help care for cancer patients whose lives were saved by bone marrow transplants. For all physicians, but especially for the patients and their families, the illness became more frustrating when we were prevented from giving a bone marrow transplant because we could not find a perfect donor match in the family or the community.”

“Dr. Bhatia’s discovery could permit us to help this important group of patients.”

Source: McMaster University
Contact: Veronica McGuire

Reference:
Direct conversion of human fibroblasts to multilineage blood progenitors
Eva Szabo, Shravanti Rampalli, Ruth M. Risueño, Angelique Schnerch, Ryan Mitchell, Aline Fiebig-Comyn, Marilyne Levadoux-Martin & Mickie Bhatia
Nature advance online publication 7 November 2010, doi:10.1038/nature09591
.........


ZenMaster


For more on stem cells and cloning, go to CellNEWS at
http://cellnews-blog.blogspot.com/